Inhibitors of ANF metabolism. Potential therapeutic agents in cardiovascular disease.
- 1 July 1990
- journal article
- editorial
- Published by Wolters Kluwer Health in Circulation
- Vol. 82 (1) , 313-315
- https://doi.org/10.1161/01.cir.82.1.313
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Atrial natriuretic factor-potentiating and antihypertensive activity of SCH 34826. An orally active neutral metalloendopeptidase inhibitor.Hypertension, 1990
- Degradation of Atrial Natriuretic PeptideJournal of Cardiovascular Pharmacology, 1989
- Potentiation of renal effects of atrial natriuretic factor-(99-126) by SQ 29,072.Hypertension, 1989
- Antihypertensive effect of a 5-day infusion of atrial natriuretic factor in humans.Hypertension, 1989
- Cardiorenal effects of atrial natriuretic factor administration in congestive heart failure: Natriuresis and diuresis without hemodynamic alterationsThe Lancet Healthy Longevity, 1989
- Role of endopeptidase‐24.11 in the inactivation of atrial natriuretic peptideFEBS Letters, 1988
- Physiological Role of Silent Receptors of Atrial Natriuretic FactorScience, 1987
- Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion.Journal of Clinical Investigation, 1986
- Long-term hypotensive and renal effects of atrial natriuretic peptide.Hypertension, 1986
- Atriopeptins as cardiac hormones.Hypertension, 1985